Table 5 Post-transplant outcomes of heart failure groups
From: Determinants of survival following heart transplantation in adults with congenital heart disease
Ischemic cardiomyopathy (n = 14,236) | Nonischemic cardiomyopathy (n = 20,676) | Congenital cardiomyopathy (n = 1040) | P value | |
|---|---|---|---|---|
Postop stroke | 419 (2.9%) | 459 (2.2%) | 36 (3.5%) | < 0.001 |
Postop dialysis | 1513 (19.6%) | 2059 (10.0%) | 214 (20.6%) | < 0.001 |
Postop pacemaker | 458 (3.2%) | 673 (3.3%) | 28 (2.7%) | 0.604 |
Death from primary graft failure | 225 (1.6%) | 300 (1.5%) | 24 (2.3%) | 0.071 |
Death from hyperacute rejection | 19 (0.1%) | 17 (0.1%) | 2 (0.2%) | 0.240 |
Death from acute rejection | 157 (1.1%) | 447 (2.2%) | 24 (2.3%) | < 0.001 |
Death from chronic rejection with graft vasculopathy | 244 (1.7%) | 389 (1.9%) | 18 (1.7%) | 0.505 |